封面
市場調查報告書
商品編碼
1998835

2026 年至 2035 年病患監測設備的市場機會、成長要素、產業趨勢與預測。

Patient Monitoring Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年全球病患監測設備市場價值為517億美元,預計到2035年將以9.1%的複合年成長率成長至1221億美元。

病患監護設備市場-IMG1

受慢性病患病率上升、人口老化、技術進步以及新興經濟體醫療保健支出增加等因素的推動,該市場正經歷強勁成長。隨著人口老化,需要持續監測的心血管、呼吸系統和代謝性疾病發生率不斷上升,推動了市場需求。病患監測設備的創新,特別是物聯網和人工智慧技術的融合,實現了即時健康數據收集、預測分析和自動化決策。這些進步使臨床醫生能夠及早發現風險並提供個人化護理。現代設備具備無線連接、雲端資料管理、模組化設計和更佳的便攜性,提高了重症監護、手術和居家照護等場景的工作流程效率。先進的監視器即使在惡劣環境下也能提供可靠的測量數據,幫助醫療專業人員更快、更準確地做出臨床決策,進而改善全球患者的治療效果。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 517億美元
預測金額 1221億美元
複合年成長率 9.1%

預計到2025年,多參數監視器市場規模將達到184億美元,佔整個市場的35.6%。多參數監視器可同時監測多項生命徵象,並將資料整合到單一平台上。它們廣泛應用於重症監護室、手術室和急診醫療環境,提供可自訂的配置、高解析度顯示器和模組化設計,以實現以患者為中心的監護。

預計2025年,傳統床邊監護設備市場規模將達338億美元。傳統床邊監護設備是固定式設備,用於追蹤心率、血壓、血氧飽和度和體溫等關鍵生理參數。這些設備已成為醫院的標準配置,用於在重症監護室、普通病房和手術室進行持續監測,從而可靠地評估基本生命徵象。

預計到2025年,美國病患監測設備市場規模將達到202億美元,主要促進因素是需要持續監測的慢性疾病(例如心血管疾病和呼吸系統疾病)盛行率的不斷上升。美國先進的醫療基礎設施、龐大的手術量以及對數位醫療解決方案的投資,進一步加速了市場成長,推動了從傳統監視器向具有集中式監護功能和電子健康記錄(EHR)兼容性的整合無線系統的轉變。

目錄

第1章:調查方法和範圍

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 慢性病盛行率增加
      • 新興經濟體可支配收入和醫療保健支出不斷成長
      • 病患監測設備的技術進步
      • 老年人口增加
    • 產業潛在風險與挑戰
      • 設備高成本
      • 嚴格的法規環境
    • 市場機遇
      • 擴大人工智慧驅動的預測性監測工具的應用
  • 成長潛力分析
  • 監理情勢(基於初步調查)
    • 北美洲
    • 歐洲
    • 亞太地區
  • 技術進步
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢
  • 波特五力分析
  • PESTEL 分析

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 業務拓展計劃

第5章 市場估價與預測:依產品分類,2022-2035年

  • 心臟監測設備
    • 心電圖儀
    • 植物型循環記錄器
    • 攜帶式心電遙測監視器
    • 智慧型穿戴式心電圖貼片
  • 神經監測設備
    • 腦電圖(EEG)測量設備
    • 腦氧飽和度監測儀
    • 顱內壓監測器
    • 肌電圖(EMG)設備
  • 呼吸監測設備
    • 脈搏血氧飽和度分析儀
    • 肺計量計
    • 二氧化碳測量儀
    • 峰值流量計
  • 麻醉監控器
  • 血流動力學監測裝置
  • 胎兒和新生兒監護
  • 多參數監視器
  • 其他產品

第6章 市場估計與預測:依類型分類,2022-2035年

  • 傳統的
  • 無線的

第7章 市場估計與預測:依最終用途分類,2022-2035年

  • 醫院
  • 門診手術中心
  • 居家醫療設施
  • 其他最終用戶

第8章 市場估計與預測:依地區分類,2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第9章:公司簡介

  • Becton Dickinson and Company
  • Biotronik
  • EPSIMED
  • Fukuda Denshi
  • GE Healthcare
  • HILLROM & WELCH ALLYN
  • Koninklijke Philips
  • Medion
  • Medtronic
  • Natus Medical
  • Nihon Kohden Corporation
  • OMRON Corporation
  • OSI Systems
  • Shenzhen Mindray Bio-Medical Electronics
  • Skanray Technologies
簡介目錄
Product Code: 4069

The Global Patient Monitoring Devices Market was valued at USD 51.7 billion in 2025 and is estimated to grow at a CAGR of 9.1% to reach USD 122.1 billion by 2035.

Patient Monitoring Devices Market - IMG1

The market is witnessing strong expansion owing to the rising prevalence of chronic diseases, increasing geriatric populations, technological advancements, and higher healthcare spending in emerging economies. Aging demographics are driving demand, as older populations face a growing incidence of cardiovascular, respiratory, and metabolic conditions that require continuous monitoring. Innovations in patient monitoring devices, particularly the integration of IoT and AI technologies, allow real-time health data collection, predictive analytics, and automated decision-making. These advancements enable clinicians to detect risks early and deliver personalized care. Modern devices now offer wireless connectivity, cloud-based data management, modular designs, and improved portability, enhancing workflow efficiency in critical care, surgical, and home care settings. Advanced monitors provide reliable measurements even under challenging conditions, helping healthcare professionals make faster, accurate clinical decisions while improving patient outcomes globally.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$51.7 Billion
Forecast Value$122.1 Billion
CAGR9.1%

The multiparameter devices segment reached USD 18.4 billion in 2025, representing 35.6%. Multiparameter monitors track multiple vital signs simultaneously, consolidating data on a single platform. They are widely used in ICUs, operating rooms, and emergency care settings, offering customizable settings, high-resolution displays, and modular configurations for tailored patient monitoring.

The conventional segment accounted for USD 33.8 billion in 2025. Conventional bedside monitoring devices are stationary units that track core physiological parameters such as heart rate, blood pressure, oxygen saturation, and temperature. These devices are standard in hospitals for continuous monitoring in ICUs, general wards, and operating rooms, offering reliable and basic vital sign assessment.

U.S. Patient Monitoring Devices Market reached USD 20.2 billion in 2025, driven by the rising prevalence of chronic illnesses, including cardiovascular and respiratory diseases, which necessitate ongoing monitoring. The country's advanced healthcare infrastructure, high surgical volumes, and investment in digital health solutions support the transition from conventional monitors to integrated, wireless systems with centralized monitoring and EHR compatibility, further accelerating market growth.

Key players in the Global Patient Monitoring Devices Market include Medtronic, Koninklijke Philips, GE Healthcare, Fukuda Denshi, Becton Dickinson and Company, Nihon Kohden Corporation, HILLROM & WELCH ALLYN, OSI Systems, Shenzhen Mindray Bio-Medical Electronics, Skanray Technologies, Medion, EPSIMED, Natus Medical, and Cerba Healthcare. Companies in the Global Patient Monitoring Devices Market are focusing on several strategies to strengthen their market presence. They are investing in AI, IoT, and wireless technologies to develop advanced, real-time monitoring solutions. Partnerships with hospitals, healthcare providers, and research institutions help in co-developing devices that meet clinical needs. Expanding distribution networks, enhancing after-sales services, and offering cloud-based data management platforms ensure customer retention. Firms are also focusing on modular, portable, and cost-effective solutions for homecare and remote monitoring. Continuous innovation in multiparameter and wearable devices, along with compliance with regulatory standards, helps maintain competitive advantage and expand global market share.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
    • 1.7.2 Research transparency addendum
    • 1.7.3 Source attribution framework
    • 1.7.4 Quality assurance metrics
  • 1.8 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Type trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Growing disposable income and healthcare expenditure in emerging countries
      • 3.2.1.3 Technological advancement in patient monitoring devices
      • 3.2.1.4 Growing geriatric population base
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulatory scenario
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing adoption for AI-powered predictive monitoring tools
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by Primary Research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technological advancements
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cardiac monitoring devices
    • 5.2.1 ECG devices
    • 5.2.2 Implantable loop recorders
    • 5.2.3 Mobile cardiac telemetry monitors
    • 5.2.4 Smart wearable ECG patches
  • 5.3 Neuromonitoring devices
    • 5.3.1 EEG devices
    • 5.3.2 Cerebral oximeters
    • 5.3.3 Intracranial pressure monitors
    • 5.3.4 EMG devices
  • 5.4 Respiratory monitoring devices
    • 5.4.1 Pulse oximeters
    • 5.4.2 Spirometers
    • 5.4.3 Capnographs
    • 5.4.4 Peak flow meters
  • 5.5 Anesthesia monitor
  • 5.6 Hemodynamic monitoring devices
  • 5.7 Fetal and neonatal monitoring
  • 5.8 Multiparameter devices
  • 5.9 Other products

Chapter 6 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Conventional
  • 6.3 Wireless

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Homecare settings
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Becton Dickinson and Company
  • 9.2 Biotronik
  • 9.3 EPSIMED
  • 9.4 Fukuda Denshi
  • 9.5 GE Healthcare
  • 9.6 HILLROM & WELCH ALLYN
  • 9.7 Koninklijke Philips
  • 9.8 Medion
  • 9.9 Medtronic
  • 9.10 Natus Medical
  • 9.11 Nihon Kohden Corporation
  • 9.12 OMRON Corporation
  • 9.13 OSI Systems
  • 9.14 Shenzhen Mindray Bio-Medical Electronics
  • 9.15 Skanray Technologies